商务部、江苏省人民政府：加强大数据、人工智能在药物靶标筛选、药物分子设计、医疗器械设计制造等方面的应用

Core Viewpoint - The Ministry of Commerce and the Jiangsu Provincial Government have issued a development plan for the open innovation of the entire biopharmaceutical industry chain in the China (Jiangsu) Pilot Free Trade Zone, focusing on technological innovation in biomedicine and medical devices [1] Group 1: Technological Innovation - The plan emphasizes the need to support the implementation of major national scientific and technological projects in the biopharmaceutical field [1] - It aims to leverage new research organizations to achieve breakthroughs in innovative drugs and key core technologies for high-end medical devices [1] - The application of big data and artificial intelligence in drug target screening, drug molecular design, and medical device design and manufacturing is highlighted [1] Group 2: Standardization and Industry Participation - Companies are encouraged to participate in the formulation of national and industry standards for cell and gene therapy products, artificial intelligence medical devices, biomedical materials, and in vitro diagnostic reagents [1]